|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ITGB4-PTN (FusionGDB2 ID:40369) |
Fusion Gene Summary for ITGB4-PTN |
Fusion gene summary |
Fusion gene information | Fusion gene name: ITGB4-PTN | Fusion gene ID: 40369 | Hgene | Tgene | Gene symbol | ITGB4 | PTN | Gene ID | 3691 | 5764 |
Gene name | integrin subunit beta 4 | pleiotrophin | |
Synonyms | CD104|GP150 | HARP|HB-GAM|HBBM|HBGF-8|HBGF8|HBNF|HBNF-1|NEGF1|OSF-1 | |
Cytomap | 17q25.1 | 7q33 | |
Type of gene | protein-coding | protein-coding | |
Description | integrin beta-4CD104 antigen | pleiotrophinheparin affin regulatory proteinheparin-binding brain mitogenheparin-binding growth factor 8heparin-binding growth-associated moleculeheparin-binding neurite outgrowth promoting factorheparin-binding neurite outgrowth-promoting factor 1 | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000579662, ENST00000339591, ENST00000200181, ENST00000450894, ENST00000449880, ENST00000584558, | ENST00000348225, ENST00000393083, | |
Fusion gene scores | * DoF score | 23 X 19 X 10=4370 | 8 X 3 X 7=168 |
# samples | 29 | 8 | |
** MAII score | log2(29/4370*10)=-3.91350847437303 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/168*10)=-1.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ITGB4 [Title/Abstract] AND PTN [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ITGB4(73753898)-PTN(136938384), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ITGB4-PTN seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. ITGB4-PTN seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ITGB4 | GO:0009611 | response to wounding | 19403692 |
Hgene | ITGB4 | GO:0031581 | hemidesmosome assembly | 12482924 |
Tgene | PTN | GO:0007229 | integrin-mediated signaling pathway | 19141530 |
Tgene | PTN | GO:0008284 | positive regulation of cell proliferation | 1733956 |
Tgene | PTN | GO:0043113 | receptor clustering | 27445335 |
Tgene | PTN | GO:0043932 | ossification involved in bone remodeling | 19442624 |
Tgene | PTN | GO:0048714 | positive regulation of oligodendrocyte differentiation | 27445335 |
Fusion gene breakpoints across ITGB4 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across PTN (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-85-A50M-01A | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
Top |
Fusion Gene ORF analysis for ITGB4-PTN |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000579662 | ENST00000348225 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
intron-3CDS | ENST00000579662 | ENST00000393083 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
In-frame | ENST00000339591 | ENST00000348225 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
In-frame | ENST00000339591 | ENST00000393083 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
Frame-shift | ENST00000200181 | ENST00000348225 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
Frame-shift | ENST00000200181 | ENST00000393083 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
Frame-shift | ENST00000450894 | ENST00000348225 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
Frame-shift | ENST00000450894 | ENST00000393083 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
Frame-shift | ENST00000449880 | ENST00000348225 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
Frame-shift | ENST00000449880 | ENST00000393083 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
intron-3CDS | ENST00000584558 | ENST00000348225 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
intron-3CDS | ENST00000584558 | ENST00000393083 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000339591 | ITGB4 | chr17 | 73753898 | - | ENST00000348225 | PTN | chr7 | 136938384 | - | 6938 | 5867 | 163 | 5604 | 1813 |
ENST00000339591 | ITGB4 | chr17 | 73753898 | - | ENST00000393083 | PTN | chr7 | 136938384 | - | 7014 | 5867 | 163 | 5604 | 1813 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000339591 | ENST00000348225 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - | 0.001685252 | 0.99831474 |
ENST00000339591 | ENST00000393083 | ITGB4 | chr17 | 73753898 | - | PTN | chr7 | 136938384 | - | 0.001642888 | 0.9983571 |
Top |
Fusion Genomic Features for ITGB4-PTN |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ITGB4-PTN |
Go to FGviewer for the breakpoints of chr17:73753898-chr7:136938384 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 1129_1218 | 1910.6666666666667 | 1823.0 | Domain | Fibronectin type-III 1 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 1222_1321 | 1910.6666666666667 | 1823.0 | Domain | Fibronectin type-III 2 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 131_329 | 1910.6666666666667 | 1823.0 | Domain | Note=VWFA |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 1530_1625 | 1910.6666666666667 | 1823.0 | Domain | Fibronectin type-III 3 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 1643_1739 | 1910.6666666666667 | 1823.0 | Domain | Fibronectin type-III 4 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 29_73 | 1910.6666666666667 | 1823.0 | Domain | Note=PSI |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 979_1084 | 1910.6666666666667 | 1823.0 | Domain | Note=Calx-beta |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 1129_1218 | 1893.3333333333333 | 1806.0 | Domain | Fibronectin type-III 1 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 1222_1321 | 1893.3333333333333 | 1806.0 | Domain | Fibronectin type-III 2 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 131_329 | 1893.3333333333333 | 1806.0 | Domain | Note=VWFA |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 1530_1625 | 1893.3333333333333 | 1806.0 | Domain | Fibronectin type-III 3 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 1643_1739 | 1893.3333333333333 | 1806.0 | Domain | Fibronectin type-III 4 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 29_73 | 1893.3333333333333 | 1806.0 | Domain | Note=PSI |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 979_1084 | 1893.3333333333333 | 1806.0 | Domain | Note=Calx-beta |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 1129_1218 | 1893.6666666666667 | 1806.0 | Domain | Fibronectin type-III 1 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 1222_1321 | 1893.6666666666667 | 1806.0 | Domain | Fibronectin type-III 2 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 131_329 | 1893.6666666666667 | 1806.0 | Domain | Note=VWFA |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 1530_1625 | 1893.6666666666667 | 1806.0 | Domain | Fibronectin type-III 3 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 1643_1739 | 1893.6666666666667 | 1806.0 | Domain | Fibronectin type-III 4 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 29_73 | 1893.6666666666667 | 1806.0 | Domain | Note=PSI |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 979_1084 | 1893.6666666666667 | 1806.0 | Domain | Note=Calx-beta |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 1129_1218 | 1839.6666666666667 | 1753.0 | Domain | Fibronectin type-III 1 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 1222_1321 | 1839.6666666666667 | 1753.0 | Domain | Fibronectin type-III 2 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 131_329 | 1839.6666666666667 | 1753.0 | Domain | Note=VWFA |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 1530_1625 | 1839.6666666666667 | 1753.0 | Domain | Fibronectin type-III 3 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 1643_1739 | 1839.6666666666667 | 1753.0 | Domain | Fibronectin type-III 4 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 29_73 | 1839.6666666666667 | 1753.0 | Domain | Note=PSI |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 979_1084 | 1839.6666666666667 | 1753.0 | Domain | Note=Calx-beta |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 194_199 | 1910.6666666666667 | 1823.0 | Region | Involved in NRG1- and IGF1-binding |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 456_619 | 1910.6666666666667 | 1823.0 | Region | Note=Cysteine-rich tandem repeats |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 732_749 | 1910.6666666666667 | 1823.0 | Region | Note=Palmitoylated on several cysteines |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 194_199 | 1893.3333333333333 | 1806.0 | Region | Involved in NRG1- and IGF1-binding |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 456_619 | 1893.3333333333333 | 1806.0 | Region | Note=Cysteine-rich tandem repeats |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 732_749 | 1893.3333333333333 | 1806.0 | Region | Note=Palmitoylated on several cysteines |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 194_199 | 1893.6666666666667 | 1806.0 | Region | Involved in NRG1- and IGF1-binding |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 456_619 | 1893.6666666666667 | 1806.0 | Region | Note=Cysteine-rich tandem repeats |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 732_749 | 1893.6666666666667 | 1806.0 | Region | Note=Palmitoylated on several cysteines |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 194_199 | 1839.6666666666667 | 1753.0 | Region | Involved in NRG1- and IGF1-binding |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 456_619 | 1839.6666666666667 | 1753.0 | Region | Note=Cysteine-rich tandem repeats |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 732_749 | 1839.6666666666667 | 1753.0 | Region | Note=Palmitoylated on several cysteines |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 456_502 | 1910.6666666666667 | 1823.0 | Repeat | Note=I |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 503_542 | 1910.6666666666667 | 1823.0 | Repeat | Note=II |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 543_581 | 1910.6666666666667 | 1823.0 | Repeat | Note=III |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 582_619 | 1910.6666666666667 | 1823.0 | Repeat | Note=IV |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 456_502 | 1893.3333333333333 | 1806.0 | Repeat | Note=I |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 503_542 | 1893.3333333333333 | 1806.0 | Repeat | Note=II |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 543_581 | 1893.3333333333333 | 1806.0 | Repeat | Note=III |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 582_619 | 1893.3333333333333 | 1806.0 | Repeat | Note=IV |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 456_502 | 1893.6666666666667 | 1806.0 | Repeat | Note=I |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 503_542 | 1893.6666666666667 | 1806.0 | Repeat | Note=II |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 543_581 | 1893.6666666666667 | 1806.0 | Repeat | Note=III |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 582_619 | 1893.6666666666667 | 1806.0 | Repeat | Note=IV |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 456_502 | 1839.6666666666667 | 1753.0 | Repeat | Note=I |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 503_542 | 1839.6666666666667 | 1753.0 | Repeat | Note=II |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 543_581 | 1839.6666666666667 | 1753.0 | Repeat | Note=III |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 582_619 | 1839.6666666666667 | 1753.0 | Repeat | Note=IV |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 28_710 | 1910.6666666666667 | 1823.0 | Topological domain | Extracellular |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 734_1822 | 1910.6666666666667 | 1823.0 | Topological domain | Cytoplasmic |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 28_710 | 1893.3333333333333 | 1806.0 | Topological domain | Extracellular |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 734_1822 | 1893.3333333333333 | 1806.0 | Topological domain | Cytoplasmic |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 28_710 | 1893.6666666666667 | 1806.0 | Topological domain | Extracellular |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 734_1822 | 1893.6666666666667 | 1806.0 | Topological domain | Cytoplasmic |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 28_710 | 1839.6666666666667 | 1753.0 | Topological domain | Extracellular |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 734_1822 | 1839.6666666666667 | 1753.0 | Topological domain | Cytoplasmic |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000200181 | - | 40 | 40 | 711_733 | 1910.6666666666667 | 1823.0 | Transmembrane | Helical |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000339591 | - | 40 | 40 | 711_733 | 1893.3333333333333 | 1806.0 | Transmembrane | Helical |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000449880 | - | 39 | 39 | 711_733 | 1893.6666666666667 | 1806.0 | Transmembrane | Helical |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000450894 | - | 39 | 39 | 711_733 | 1839.6666666666667 | 1753.0 | Transmembrane | Helical |
Tgene | PTN | chr17:73753898 | chr7:136938384 | ENST00000348225 | 1 | 5 | 123_131 | 38.333333333333336 | 169.0 | Region | Chondroitin sulfate binding | |
Tgene | PTN | chr17:73753898 | chr7:136938384 | ENST00000348225 | 1 | 5 | 147_168 | 38.333333333333336 | 169.0 | Region | Chondroitin sulfate A binding | |
Tgene | PTN | chr17:73753898 | chr7:136938384 | ENST00000348225 | 1 | 5 | 92_99 | 38.333333333333336 | 169.0 | Region | Chondroitin sulfate binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 1129_1218 | 0 | 1753.0 | Domain | Fibronectin type-III 1 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 1222_1321 | 0 | 1753.0 | Domain | Fibronectin type-III 2 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 131_329 | 0 | 1753.0 | Domain | Note=VWFA |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 1530_1625 | 0 | 1753.0 | Domain | Fibronectin type-III 3 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 1643_1739 | 0 | 1753.0 | Domain | Fibronectin type-III 4 |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 29_73 | 0 | 1753.0 | Domain | Note=PSI |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 979_1084 | 0 | 1753.0 | Domain | Note=Calx-beta |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 194_199 | 0 | 1753.0 | Region | Involved in NRG1- and IGF1-binding |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 456_619 | 0 | 1753.0 | Region | Note=Cysteine-rich tandem repeats |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 732_749 | 0 | 1753.0 | Region | Note=Palmitoylated on several cysteines |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 456_502 | 0 | 1753.0 | Repeat | Note=I |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 503_542 | 0 | 1753.0 | Repeat | Note=II |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 543_581 | 0 | 1753.0 | Repeat | Note=III |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 582_619 | 0 | 1753.0 | Repeat | Note=IV |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 28_710 | 0 | 1753.0 | Topological domain | Extracellular |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 734_1822 | 0 | 1753.0 | Topological domain | Cytoplasmic |
Hgene | ITGB4 | chr17:73753898 | chr7:136938384 | ENST00000579662 | - | 1 | 39 | 711_733 | 0 | 1753.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for ITGB4-PTN |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000339591_ENST00000348225_TCGA-85-A50M-01A_ITGB4_chr17_73753898_-_PTN_chr7_136938384_length(transcript)=6938nt_BP=5867nt GCGCTGCCCGCCTCGTCCCCACCCCCCCAACCCCCGCGCCCGCCCTCGGACAGTCCCTGCTCGCCCGCGCGCTGCAGCCCCATCTCCTAG CGGCAGCCCAGGCGCGGAGGGAGCGAGTCCGCCCCGAGGTAGGTCCAGGACGGGCGCACAGCAGCAGCCGAGGCTGGCCGGGAGAGGGAG GAAGAGGATGGCAGGGCCACGCCCCAGCCCATGGGCCAGGCTGCTCCTGGCAGCCTTGATCAGCGTCAGCCTCTCTGGGACCTTGGCAAA CCGCTGCAAGAAGGCCCCAGTGAAGAGCTGCACGGAGTGTGTCCGTGTGGATAAGGACTGCGCCTACTGCACAGACGAGATGTTCAGGGA CCGGCGCTGCAACACCCAGGCGGAGCTGCTGGCCGCGGGCTGCCAGCGGGAGAGCATCGTGGTCATGGAGAGCAGCTTCCAAATCACAGA GGAGACCCAGATTGACACCACCCTGCGGCGCAGCCAGATGTCCCCCCAAGGCCTGCGGGTCCGTCTGCGGCCCGGTGAGGAGCGGCATTT TGAGCTGGAGGTGTTTGAGCCACTGGAGAGCCCCGTGGACCTGTACATCCTCATGGACTTCTCCAACTCCATGTCCGATGATCTGGACAA CCTCAAGAAGATGGGGCAGAACCTGGCTCGGGTCCTGAGCCAGCTCACCAGCGACTACACTATTGGATTTGGCAAGTTTGTGGACAAAGT CAGCGTCCCGCAGACGGACATGAGGCCTGAGAAGCTGAAGGAGCCCTGGCCCAACAGTGACCCCCCCTTCTCCTTCAAGAACGTCATCAG CCTGACAGAAGATGTGGATGAGTTCCGGAATAAACTGCAGGGAGAGCGGATCTCAGGCAACCTGGATGCTCCTGAGGGCGGCTTCGATGC CATCCTGCAGACAGCTGTGTGCACGAGGGACATTGGCTGGCGCCCGGACAGCACCCACCTGCTGGTCTTCTCCACCGAGTCAGCCTTCCA CTATGAGGCTGATGGCGCCAACGTGCTGGCTGGCATCATGAGCCGCAACGATGAACGGTGCCACCTGGACACCACGGGCACCTACACCCA GTACAGGACACAGGACTACCCGTCGGTGCCCACCCTGGTGCGCCTGCTCGCCAAGCACAACATCATCCCCATCTTTGCTGTCACCAACTA CTCCTATAGCTACTACGAGAAGCTTCACACCTATTTCCCTGTCTCCTCACTGGGGGTGCTGCAGGAGGACTCGTCCAACATCGTGGAGCT GCTGGAGGAGGCCTTCAATCGGATCCGCTCCAACCTGGACATCCGGGCCCTAGACAGCCCCCGAGGCCTTCGGACAGAGGTCACCTCCAA GATGTTCCAGAAGACGAGGACTGGGTCCTTTCACATCCGGCGGGGGGAAGTGGGTATATACCAGGTGCAGCTGCGGGCCCTTGAGCACGT GGATGGGACGCACGTGTGCCAGCTGCCGGAGGACCAGAAGGGCAACATCCATCTGAAACCTTCCTTCTCCGACGGCCTCAAGATGGACGC GGGCATCATCTGTGATGTGTGCACCTGCGAGCTGCAAAAAGAGGTGCGGTCAGCTCGCTGCAGCTTCAACGGAGACTTCGTGTGCGGACA GTGTGTGTGCAGCGAGGGCTGGAGTGGCCAGACCTGCAACTGCTCCACCGGCTCTCTGAGTGACATTCAGCCCTGCCTGCGGGAGGGCGA GGACAAGCCGTGCTCCGGCCGTGGGGAGTGCCAGTGCGGGCACTGTGTGTGCTACGGCGAAGGCCGCTACGAGGGTCAGTTCTGCGAGTA TGACAACTTCCAGTGTCCCCGCACTTCCGGGTTCCTCTGCAATGACCGAGGACGCTGCTCCATGGGCCAGTGTGTGTGTGAGCCTGGTTG GACAGGCCCAAGCTGTGACTGTCCCCTCAGCAATGCCACCTGCATCGACAGCAATGGGGGCATCTGTAATGGACGTGGCCACTGTGAGTG TGGCCGCTGCCACTGCCACCAGCAGTCGCTCTACACGGACACCATCTGCGAGATCAACTACTCGGCGATCCACCCGGGCCTCTGCGAGGA CCTACGCTCCTGCGTGCAGTGCCAGGCGTGGGGCACCGGCGAGAAGAAGGGGCGCACGTGTGAGGAATGCAACTTCAAGGTCAAGATGGT GGACGAGCTTAAGAGAGCCGAGGAGGTGGTGGTGCGCTGCTCCTTCCGGGACGAGGATGACGACTGCACCTACAGCTACACCATGGAAGG TGACGGCGCCCCTGGGCCCAACAGCACTGTCCTGGTGCACAAGAAGAAGGACTGCCCTCCGGGCTCCTTCTGGTGGCTCATCCCCCTGCT CCTCCTCCTCCTGCCGCTCCTGGCCCTGCTACTGCTGCTATGCTGGAAGTACTGTGCCTGCTGCAAGGCCTGCCTGGCACTTCTCCCGTG CTGCAACCGAGGTCACATGGTGGGCTTTAAGGAAGACCACTACATGCTGCGGGAGAACCTGATGGCCTCTGACCACTTGGACACGCCCAT GCTGCGCAGCGGGAACCTCAAGGGCCGTGACGTGGTCCGCTGGAAGGTCACCAACAACATGCAGCGGCCTGGCTTTGCCACTCATGCCGC CAGCATCAACCCCACAGAGCTGGTGCCCTACGGGCTGTCCTTGCGCCTGGCCCGCCTTTGCACCGAGAACCTGCTGAAGCCTGACACTCG GGAGTGCGCCCAGCTGCGCCAGGAGGTGGAGGAGAACCTGAACGAGGTCTACAGGCAGATCTCCGGTGTACACAAGCTCCAGCAGACCAA GTTCCGGCAGCAGCCCAATGCCGGGAAAAAGCAAGACCACACCATTGTGGACACAGTGCTGATGGCGCCCCGCTCGGCCAAGCCGGCCCT GCTGAAGCTTACAGAGAAGCAGGTGGAACAGAGGGCCTTCCACGACCTCAAGGTGGCCCCCGGCTACTACACCCTCACTGCAGACCAGGA CGCCCGGGGCATGGTGGAGTTCCAGGAGGGCGTGGAGCTGGTGGACGTACGGGTGCCCCTCTTTATCCGGCCTGAGGATGACGACGAGAA GCAGCTGCTGGTGGAGGCCATCGACGTGCCCGCAGGCACTGCCACCCTCGGCCGCCGCCTGGTAAACATCACCATCATCAAGGAGCAAGC CAGAGACGTGGTGTCCTTTGAGCAGCCTGAGTTCTCGGTCAGCCGCGGGGACCAGGTGGCCCGCATCCCTGTCATCCGGCGTGTCCTGGA CGGCGGGAAGTCCCAGGTCTCCTACCGCACACAGGATGGCACCGCGCAGGGCAACCGGGACTACATCCCCGTGGAGGGTGAGCTGCTGTT CCAGCCTGGGGAGGCCTGGAAAGAGCTGCAGGTGAAGCTCCTGGAGCTGCAAGAAGTTGACTCCCTCCTGCGGGGCCGCCAGGTCCGCCG TTTCCACGTCCAGCTCAGCAACCCTAAGTTTGGGGCCCACCTGGGCCAGCCCCACTCCACCACCATCATCATCAGGGACCCAGATGAACT GGACCGGAGCTTCACGAGTCAGATGTTGTCATCACAGCCACCCCCTCACGGCGACCTGGGCGCCCCGCAGAACCCCAATGCTAAGGCCGC TGGGTCCAGGAAGATCCATTTCAACTGGCTGCCCCCTTCTGGCAAGCCAATGGGGTACAGGGTAAAGTACTGGATTCAGGGTGACTCCGA ATCCGAAGCCCACCTGCTCGACAGCAAGGTGCCCTCAGTGGAGCTCACCAACCTGTACCCGTATTGCGACTATGAGATGAAGGTGTGCGC CTACGGGGCTCAGGGCGAGGGACCCTACAGCTCCCTGGTGTCCTGCCGCACCCACCAGGAAGTGCCCAGCGAGCCAGGGCGTCTGGCCTT CAATGTCGTCTCCTCCACGGTGACCCAGCTGAGCTGGGCTGAGCCGGCTGAGACCAACGGTGAGATCACAGCCTACGAGGTCTGCTATGG CCTGGTCAACGATGACAACCGACCTATTGGGCCCATGAAGAAAGTGCTGGTTGACAACCCTAAGAACCGGATGCTGCTTATTGAGAACCT TCGGGAGTCCCAGCCCTACCGCTACACGGTGAAGGCGCGCAACGGGGCCGGCTGGGGGCCTGAGCGGGAGGCCATCATCAACCTGGCCAC CCAGCCCAAGAGGCCCATGTCCATCCCCATCATCCCTGACATCCCTATCGTGGACGCCCAGAGCGGGGAGGACTACGACAGCTTCCTTAT GTACAGCGATGACGTTCTACGCTCTCCATCGGGCAGCCAGAGGCCCAGCGTCTCCGATGACACTGAGCACCTGGTGAATGGCCGGATGGA CTTTGCCTTCCCGGGCAGCACCAACTCCCTGCACAGGATGACCACGACCAGTGCTGCTGCCTATGGCACCCACCTGAGCCCACACGTGCC CCACCGCGTGCTAAGCACATCCTCCACCCTCACACGGGACTACAACTCACTGACCCGCTCAGAACACTCACACTCGACCACACTGCCCAG GGACTACTCCACCCTCACCTCCGTCTCCTCCCACGGCCTCCCTCCCATCTGGGAACACGGGAGGAGCAGGCTTCCGCTGTCCTGGGCCCT GGGGTCCCGGAGTCGGGCTCAGATGAAAGGGTTCCCCCCTTCCAGGGGCCCACGAGACTCTATAATCCTGGCTGGGAGGCCAGCAGCGCC CTCCTGGGGCCCAGACTCTCGCCTGACTGCTGGTGTGCCCGACACGCCCACCCGCCTGGTGTTCTCTGCCCTGGGGCCCACATCTCTCAG AGTGAGCTGGCAGGAGCCGCGGTGCGAGCGGCCGCTGCAGGGCTACAGTGTGGAGTACCAGCTGCTGAACGGCGGTGAGCTGCATCGGCT CAACATCCCCAACCCTGCCCAGACCTCGGTGGTGGTGGAAGACCTCCTGCCCAACCACTCCTACGTGTTCCGCGTGCGGGCCCAGAGCCA GGAAGGCTGGGGCCGAGAGCGTGAGGGTGTCATCACCATTGAATCCCAGGTGCACCCGCAGAGCCCACTGTGTCCCCTGCCAGGCTCCGC CTTCACTTTGAGCACTCCCAGTGCCCCAGGCCCGCTGGTGTTCACTGCCCTGAGCCCAGACTCGCTGCAGCTGAGCTGGGAGCGGCCACG GAGGCCCAATGGGGATATCGTCGGCTACCTGGTGACCTGTGAGATGGCCCAAGGAGGAGGGCCAGCCACCGCATTCCGGGTGGATGGAGA CAGCCCCGAGAGCCGGCTGACCGTGCCGGGCCTCAGCGAGAACGTGCCCTACAAGTTCAAGGTGCAGGCCAGGACCACTGAGGGCTTCGG GCCAGAGCGCGAGGGCATCATCACCATAGAGTCCCAGGATGGAGGACCCTTCCCGCAGCTGGGCAGCCGTGCCGGGCTCTTCCAGCACCC GCTGCAAAGCGAGTACAGCAGCATCACCACCACCCACACCAGCGCCACCGAGCCCTTCCTAGTGGATGGGCTGACCCTGGGGGCCCAGCA CCTGGAGGCAGGCGGCTCCCTCACCCGGCATGTGACCCAGGAGTTTGTGAGCCGGACACTGACCACCAGCGGAACCCTTAGCACCCACAT GGACCAACAGTTCTTCCAAACTTGACCGCACCCTGCCCCACCCCCGCCACGTCCCACTAGGCGTCCTCCCGACTCCTCTCCCGGAGCCTC CTCAGCTACTCCATCCTTGCACCCCTGGGGGCCCAGCCCACCCGCATGCACAGAGCAGGGGCTAGGTGTCTCCTGGGAGGCATGAAGGGG GCAAGGTCCGTCCTCTGTGGGCCCAAACCTATTTGTAACCAAAGAGCTGGGAGCAGCACAAGGACCCAGCCTTTGTTCTGCACTTAATAA ATGGTTTTGCTACTGCTAAAAAAAAGTGAAGAAGTCTGACTGTGGAGAATGGCAGTGGAGTGTGTGTGTGCCCACCAGTGGAGACTGTGG GCTGGGCACACGGGAGGGCACTCGGACTGGAGCTGAGTGCAAGCAAACCATGAAGACCCAGAGATGTAAGATCCCCTGCAACTGGAAGAA GCAATTTGGCGCGGAGTGCAAATACCAGTTCCAGGCCTGGGGAGAATGTGACCTGAACACAGCCCTGAAGACCAGAACTGGAAGTCTGAA GCGAGCCCTGCACAATGCCGAATGCCAGAAGACTGTCACCATCTCCAAGCCCTGTGGCAAACTGACCAAGCCCAAACCTCAAGCAGAATC TAAGAAGAAGAAAAAGGAAGGCAAGAAACAGGAGAAGATGCTGGATTAAAAGATGTCACCTGTGGAACATAAAAAGGACATCAGCAAACA GGATCAGTTAACTATTGCATTTATATGTACCGTAGGCTTTGTATTCAAAAATTATCTATAGCTAAGTACACAATAAGCAAAAACAAAAAG AAAAGAAAATTTTTGTAGTAGCGTTTTTTAAATGTATACTATAGTACCAGTAGGGGCTTATAATAAAGGACTGTAATCTTATTTAGGAAG TTGACTTATAGTACATGATAAATGATAGACAATTGAGGTAAGTTTTTTGAAATTATGTGACATTTTACATTAAATTTTTTTTACATTTTT TGGGCAGCAATTTAAATGTTATGACTATGTAAACTACTTCTCTTGTTAGGTAATTTTTTTCACCTAGATTTTTTTCCCAATTGAGAAAAA TATATACTAAACAAAATAGCAATAAAACATAATCACTCTATTTGAAGAAAATATCTTGTTTTCTGCCAATAGATTTTTTAAAATGTAGTC AGCAAAATGGGGGTGGGGAAGCAGAGCATGTCCTAGTTCAATGTTGACTTTTTTTTTTTTTAAAGAAAAGCATTAAGACATAAAATTCTT TCACTTTGGCAGAAGCATTTGTTTTCTTGATGAAATTATTTTTCCATCTGAGGAAAAAAATACTAGGAAAATAAATCAAGGTGATGCTGA >In-frame_ENST00000339591_ENST00000348225_TCGA-85-A50M-01A_ITGB4_chr17_73753898_-_PTN_chr7_136938384_length(amino acids)=1813AA_start in transcript=163_stop in transcript=5604 MAGRGRKRMAGPRPSPWARLLLAALISVSLSGTLANRCKKAPVKSCTECVRVDKDCAYCTDEMFRDRRCNTQAELLAAGCQRESIVVMES SFQITEETQIDTTLRRSQMSPQGLRVRLRPGEERHFELEVFEPLESPVDLYILMDFSNSMSDDLDNLKKMGQNLARVLSQLTSDYTIGFG KFVDKVSVPQTDMRPEKLKEPWPNSDPPFSFKNVISLTEDVDEFRNKLQGERISGNLDAPEGGFDAILQTAVCTRDIGWRPDSTHLLVFS TESAFHYEADGANVLAGIMSRNDERCHLDTTGTYTQYRTQDYPSVPTLVRLLAKHNIIPIFAVTNYSYSYYEKLHTYFPVSSLGVLQEDS SNIVELLEEAFNRIRSNLDIRALDSPRGLRTEVTSKMFQKTRTGSFHIRRGEVGIYQVQLRALEHVDGTHVCQLPEDQKGNIHLKPSFSD GLKMDAGIICDVCTCELQKEVRSARCSFNGDFVCGQCVCSEGWSGQTCNCSTGSLSDIQPCLREGEDKPCSGRGECQCGHCVCYGEGRYE GQFCEYDNFQCPRTSGFLCNDRGRCSMGQCVCEPGWTGPSCDCPLSNATCIDSNGGICNGRGHCECGRCHCHQQSLYTDTICEINYSAIH PGLCEDLRSCVQCQAWGTGEKKGRTCEECNFKVKMVDELKRAEEVVVRCSFRDEDDDCTYSYTMEGDGAPGPNSTVLVHKKKDCPPGSFW WLIPLLLLLLPLLALLLLLCWKYCACCKACLALLPCCNRGHMVGFKEDHYMLRENLMASDHLDTPMLRSGNLKGRDVVRWKVTNNMQRPG FATHAASINPTELVPYGLSLRLARLCTENLLKPDTRECAQLRQEVEENLNEVYRQISGVHKLQQTKFRQQPNAGKKQDHTIVDTVLMAPR SAKPALLKLTEKQVEQRAFHDLKVAPGYYTLTADQDARGMVEFQEGVELVDVRVPLFIRPEDDDEKQLLVEAIDVPAGTATLGRRLVNIT IIKEQARDVVSFEQPEFSVSRGDQVARIPVIRRVLDGGKSQVSYRTQDGTAQGNRDYIPVEGELLFQPGEAWKELQVKLLELQEVDSLLR GRQVRRFHVQLSNPKFGAHLGQPHSTTIIIRDPDELDRSFTSQMLSSQPPPHGDLGAPQNPNAKAAGSRKIHFNWLPPSGKPMGYRVKYW IQGDSESEAHLLDSKVPSVELTNLYPYCDYEMKVCAYGAQGEGPYSSLVSCRTHQEVPSEPGRLAFNVVSSTVTQLSWAEPAETNGEITA YEVCYGLVNDDNRPIGPMKKVLVDNPKNRMLLIENLRESQPYRYTVKARNGAGWGPEREAIINLATQPKRPMSIPIIPDIPIVDAQSGED YDSFLMYSDDVLRSPSGSQRPSVSDDTEHLVNGRMDFAFPGSTNSLHRMTTTSAAAYGTHLSPHVPHRVLSTSSTLTRDYNSLTRSEHSH STTLPRDYSTLTSVSSHGLPPIWEHGRSRLPLSWALGSRSRAQMKGFPPSRGPRDSIILAGRPAAPSWGPDSRLTAGVPDTPTRLVFSAL GPTSLRVSWQEPRCERPLQGYSVEYQLLNGGELHRLNIPNPAQTSVVVEDLLPNHSYVFRVRAQSQEGWGREREGVITIESQVHPQSPLC PLPGSAFTLSTPSAPGPLVFTALSPDSLQLSWERPRRPNGDIVGYLVTCEMAQGGGPATAFRVDGDSPESRLTVPGLSENVPYKFKVQAR TTEGFGPEREGIITIESQDGGPFPQLGSRAGLFQHPLQSEYSSITTTHTSATEPFLVDGLTLGAQHLEAGGSLTRHVTQEFVSRTLTTSG -------------------------------------------------------------- >In-frame_ENST00000339591_ENST00000393083_TCGA-85-A50M-01A_ITGB4_chr17_73753898_-_PTN_chr7_136938384_length(transcript)=7014nt_BP=5867nt GCGCTGCCCGCCTCGTCCCCACCCCCCCAACCCCCGCGCCCGCCCTCGGACAGTCCCTGCTCGCCCGCGCGCTGCAGCCCCATCTCCTAG CGGCAGCCCAGGCGCGGAGGGAGCGAGTCCGCCCCGAGGTAGGTCCAGGACGGGCGCACAGCAGCAGCCGAGGCTGGCCGGGAGAGGGAG GAAGAGGATGGCAGGGCCACGCCCCAGCCCATGGGCCAGGCTGCTCCTGGCAGCCTTGATCAGCGTCAGCCTCTCTGGGACCTTGGCAAA CCGCTGCAAGAAGGCCCCAGTGAAGAGCTGCACGGAGTGTGTCCGTGTGGATAAGGACTGCGCCTACTGCACAGACGAGATGTTCAGGGA CCGGCGCTGCAACACCCAGGCGGAGCTGCTGGCCGCGGGCTGCCAGCGGGAGAGCATCGTGGTCATGGAGAGCAGCTTCCAAATCACAGA GGAGACCCAGATTGACACCACCCTGCGGCGCAGCCAGATGTCCCCCCAAGGCCTGCGGGTCCGTCTGCGGCCCGGTGAGGAGCGGCATTT TGAGCTGGAGGTGTTTGAGCCACTGGAGAGCCCCGTGGACCTGTACATCCTCATGGACTTCTCCAACTCCATGTCCGATGATCTGGACAA CCTCAAGAAGATGGGGCAGAACCTGGCTCGGGTCCTGAGCCAGCTCACCAGCGACTACACTATTGGATTTGGCAAGTTTGTGGACAAAGT CAGCGTCCCGCAGACGGACATGAGGCCTGAGAAGCTGAAGGAGCCCTGGCCCAACAGTGACCCCCCCTTCTCCTTCAAGAACGTCATCAG CCTGACAGAAGATGTGGATGAGTTCCGGAATAAACTGCAGGGAGAGCGGATCTCAGGCAACCTGGATGCTCCTGAGGGCGGCTTCGATGC CATCCTGCAGACAGCTGTGTGCACGAGGGACATTGGCTGGCGCCCGGACAGCACCCACCTGCTGGTCTTCTCCACCGAGTCAGCCTTCCA CTATGAGGCTGATGGCGCCAACGTGCTGGCTGGCATCATGAGCCGCAACGATGAACGGTGCCACCTGGACACCACGGGCACCTACACCCA GTACAGGACACAGGACTACCCGTCGGTGCCCACCCTGGTGCGCCTGCTCGCCAAGCACAACATCATCCCCATCTTTGCTGTCACCAACTA CTCCTATAGCTACTACGAGAAGCTTCACACCTATTTCCCTGTCTCCTCACTGGGGGTGCTGCAGGAGGACTCGTCCAACATCGTGGAGCT GCTGGAGGAGGCCTTCAATCGGATCCGCTCCAACCTGGACATCCGGGCCCTAGACAGCCCCCGAGGCCTTCGGACAGAGGTCACCTCCAA GATGTTCCAGAAGACGAGGACTGGGTCCTTTCACATCCGGCGGGGGGAAGTGGGTATATACCAGGTGCAGCTGCGGGCCCTTGAGCACGT GGATGGGACGCACGTGTGCCAGCTGCCGGAGGACCAGAAGGGCAACATCCATCTGAAACCTTCCTTCTCCGACGGCCTCAAGATGGACGC GGGCATCATCTGTGATGTGTGCACCTGCGAGCTGCAAAAAGAGGTGCGGTCAGCTCGCTGCAGCTTCAACGGAGACTTCGTGTGCGGACA GTGTGTGTGCAGCGAGGGCTGGAGTGGCCAGACCTGCAACTGCTCCACCGGCTCTCTGAGTGACATTCAGCCCTGCCTGCGGGAGGGCGA GGACAAGCCGTGCTCCGGCCGTGGGGAGTGCCAGTGCGGGCACTGTGTGTGCTACGGCGAAGGCCGCTACGAGGGTCAGTTCTGCGAGTA TGACAACTTCCAGTGTCCCCGCACTTCCGGGTTCCTCTGCAATGACCGAGGACGCTGCTCCATGGGCCAGTGTGTGTGTGAGCCTGGTTG GACAGGCCCAAGCTGTGACTGTCCCCTCAGCAATGCCACCTGCATCGACAGCAATGGGGGCATCTGTAATGGACGTGGCCACTGTGAGTG TGGCCGCTGCCACTGCCACCAGCAGTCGCTCTACACGGACACCATCTGCGAGATCAACTACTCGGCGATCCACCCGGGCCTCTGCGAGGA CCTACGCTCCTGCGTGCAGTGCCAGGCGTGGGGCACCGGCGAGAAGAAGGGGCGCACGTGTGAGGAATGCAACTTCAAGGTCAAGATGGT GGACGAGCTTAAGAGAGCCGAGGAGGTGGTGGTGCGCTGCTCCTTCCGGGACGAGGATGACGACTGCACCTACAGCTACACCATGGAAGG TGACGGCGCCCCTGGGCCCAACAGCACTGTCCTGGTGCACAAGAAGAAGGACTGCCCTCCGGGCTCCTTCTGGTGGCTCATCCCCCTGCT CCTCCTCCTCCTGCCGCTCCTGGCCCTGCTACTGCTGCTATGCTGGAAGTACTGTGCCTGCTGCAAGGCCTGCCTGGCACTTCTCCCGTG CTGCAACCGAGGTCACATGGTGGGCTTTAAGGAAGACCACTACATGCTGCGGGAGAACCTGATGGCCTCTGACCACTTGGACACGCCCAT GCTGCGCAGCGGGAACCTCAAGGGCCGTGACGTGGTCCGCTGGAAGGTCACCAACAACATGCAGCGGCCTGGCTTTGCCACTCATGCCGC CAGCATCAACCCCACAGAGCTGGTGCCCTACGGGCTGTCCTTGCGCCTGGCCCGCCTTTGCACCGAGAACCTGCTGAAGCCTGACACTCG GGAGTGCGCCCAGCTGCGCCAGGAGGTGGAGGAGAACCTGAACGAGGTCTACAGGCAGATCTCCGGTGTACACAAGCTCCAGCAGACCAA GTTCCGGCAGCAGCCCAATGCCGGGAAAAAGCAAGACCACACCATTGTGGACACAGTGCTGATGGCGCCCCGCTCGGCCAAGCCGGCCCT GCTGAAGCTTACAGAGAAGCAGGTGGAACAGAGGGCCTTCCACGACCTCAAGGTGGCCCCCGGCTACTACACCCTCACTGCAGACCAGGA CGCCCGGGGCATGGTGGAGTTCCAGGAGGGCGTGGAGCTGGTGGACGTACGGGTGCCCCTCTTTATCCGGCCTGAGGATGACGACGAGAA GCAGCTGCTGGTGGAGGCCATCGACGTGCCCGCAGGCACTGCCACCCTCGGCCGCCGCCTGGTAAACATCACCATCATCAAGGAGCAAGC CAGAGACGTGGTGTCCTTTGAGCAGCCTGAGTTCTCGGTCAGCCGCGGGGACCAGGTGGCCCGCATCCCTGTCATCCGGCGTGTCCTGGA CGGCGGGAAGTCCCAGGTCTCCTACCGCACACAGGATGGCACCGCGCAGGGCAACCGGGACTACATCCCCGTGGAGGGTGAGCTGCTGTT CCAGCCTGGGGAGGCCTGGAAAGAGCTGCAGGTGAAGCTCCTGGAGCTGCAAGAAGTTGACTCCCTCCTGCGGGGCCGCCAGGTCCGCCG TTTCCACGTCCAGCTCAGCAACCCTAAGTTTGGGGCCCACCTGGGCCAGCCCCACTCCACCACCATCATCATCAGGGACCCAGATGAACT GGACCGGAGCTTCACGAGTCAGATGTTGTCATCACAGCCACCCCCTCACGGCGACCTGGGCGCCCCGCAGAACCCCAATGCTAAGGCCGC TGGGTCCAGGAAGATCCATTTCAACTGGCTGCCCCCTTCTGGCAAGCCAATGGGGTACAGGGTAAAGTACTGGATTCAGGGTGACTCCGA ATCCGAAGCCCACCTGCTCGACAGCAAGGTGCCCTCAGTGGAGCTCACCAACCTGTACCCGTATTGCGACTATGAGATGAAGGTGTGCGC CTACGGGGCTCAGGGCGAGGGACCCTACAGCTCCCTGGTGTCCTGCCGCACCCACCAGGAAGTGCCCAGCGAGCCAGGGCGTCTGGCCTT CAATGTCGTCTCCTCCACGGTGACCCAGCTGAGCTGGGCTGAGCCGGCTGAGACCAACGGTGAGATCACAGCCTACGAGGTCTGCTATGG CCTGGTCAACGATGACAACCGACCTATTGGGCCCATGAAGAAAGTGCTGGTTGACAACCCTAAGAACCGGATGCTGCTTATTGAGAACCT TCGGGAGTCCCAGCCCTACCGCTACACGGTGAAGGCGCGCAACGGGGCCGGCTGGGGGCCTGAGCGGGAGGCCATCATCAACCTGGCCAC CCAGCCCAAGAGGCCCATGTCCATCCCCATCATCCCTGACATCCCTATCGTGGACGCCCAGAGCGGGGAGGACTACGACAGCTTCCTTAT GTACAGCGATGACGTTCTACGCTCTCCATCGGGCAGCCAGAGGCCCAGCGTCTCCGATGACACTGAGCACCTGGTGAATGGCCGGATGGA CTTTGCCTTCCCGGGCAGCACCAACTCCCTGCACAGGATGACCACGACCAGTGCTGCTGCCTATGGCACCCACCTGAGCCCACACGTGCC CCACCGCGTGCTAAGCACATCCTCCACCCTCACACGGGACTACAACTCACTGACCCGCTCAGAACACTCACACTCGACCACACTGCCCAG GGACTACTCCACCCTCACCTCCGTCTCCTCCCACGGCCTCCCTCCCATCTGGGAACACGGGAGGAGCAGGCTTCCGCTGTCCTGGGCCCT GGGGTCCCGGAGTCGGGCTCAGATGAAAGGGTTCCCCCCTTCCAGGGGCCCACGAGACTCTATAATCCTGGCTGGGAGGCCAGCAGCGCC CTCCTGGGGCCCAGACTCTCGCCTGACTGCTGGTGTGCCCGACACGCCCACCCGCCTGGTGTTCTCTGCCCTGGGGCCCACATCTCTCAG AGTGAGCTGGCAGGAGCCGCGGTGCGAGCGGCCGCTGCAGGGCTACAGTGTGGAGTACCAGCTGCTGAACGGCGGTGAGCTGCATCGGCT CAACATCCCCAACCCTGCCCAGACCTCGGTGGTGGTGGAAGACCTCCTGCCCAACCACTCCTACGTGTTCCGCGTGCGGGCCCAGAGCCA GGAAGGCTGGGGCCGAGAGCGTGAGGGTGTCATCACCATTGAATCCCAGGTGCACCCGCAGAGCCCACTGTGTCCCCTGCCAGGCTCCGC CTTCACTTTGAGCACTCCCAGTGCCCCAGGCCCGCTGGTGTTCACTGCCCTGAGCCCAGACTCGCTGCAGCTGAGCTGGGAGCGGCCACG GAGGCCCAATGGGGATATCGTCGGCTACCTGGTGACCTGTGAGATGGCCCAAGGAGGAGGGCCAGCCACCGCATTCCGGGTGGATGGAGA CAGCCCCGAGAGCCGGCTGACCGTGCCGGGCCTCAGCGAGAACGTGCCCTACAAGTTCAAGGTGCAGGCCAGGACCACTGAGGGCTTCGG GCCAGAGCGCGAGGGCATCATCACCATAGAGTCCCAGGATGGAGGACCCTTCCCGCAGCTGGGCAGCCGTGCCGGGCTCTTCCAGCACCC GCTGCAAAGCGAGTACAGCAGCATCACCACCACCCACACCAGCGCCACCGAGCCCTTCCTAGTGGATGGGCTGACCCTGGGGGCCCAGCA CCTGGAGGCAGGCGGCTCCCTCACCCGGCATGTGACCCAGGAGTTTGTGAGCCGGACACTGACCACCAGCGGAACCCTTAGCACCCACAT GGACCAACAGTTCTTCCAAACTTGACCGCACCCTGCCCCACCCCCGCCACGTCCCACTAGGCGTCCTCCCGACTCCTCTCCCGGAGCCTC CTCAGCTACTCCATCCTTGCACCCCTGGGGGCCCAGCCCACCCGCATGCACAGAGCAGGGGCTAGGTGTCTCCTGGGAGGCATGAAGGGG GCAAGGTCCGTCCTCTGTGGGCCCAAACCTATTTGTAACCAAAGAGCTGGGAGCAGCACAAGGACCCAGCCTTTGTTCTGCACTTAATAA ATGGTTTTGCTACTGCTAAAAAAAAGTGAAGAAGTCTGACTGTGGAGAATGGCAGTGGAGTGTGTGTGTGCCCACCAGTGGAGACTGTGG GCTGGGCACACGGGAGGGCACTCGGACTGGAGCTGAGTGCAAGCAAACCATGAAGACCCAGAGATGTAAGATCCCCTGCAACTGGAAGAA GCAATTTGGCGCGGAGTGCAAATACCAGTTCCAGGCCTGGGGAGAATGTGACCTGAACACAGCCCTGAAGACCAGAACTGGAAGTCTGAA GCGAGCCCTGCACAATGCCGAATGCCAGAAGACTGTCACCATCTCCAAGCCCTGTGGCAAACTGACCAAGCCCAAACCTCAAGAGAAGGG AAAATGGAGACACAGGAGTGGGGAGAGTTTGAGAAGATGGTAGAGAGGAGTGTTTGGGTGAAGGGAGATGGATTCGTCTACTGATGCAAC TGCAGAATCTAAGAAGAAGAAAAAGGAAGGCAAGAAACAGGAGAAGATGCTGGATTAAAAGATGTCACCTGTGGAACATAAAAAGGACAT CAGCAAACAGGATCAGTTAACTATTGCATTTATATGTACCGTAGGCTTTGTATTCAAAAATTATCTATAGCTAAGTACACAATAAGCAAA AACAAAAAGAAAAGAAAATTTTTGTAGTAGCGTTTTTTAAATGTATACTATAGTACCAGTAGGGGCTTATAATAAAGGACTGTAATCTTA TTTAGGAAGTTGACTTATAGTACATGATAAATGATAGACAATTGAGGTAAGTTTTTTGAAATTATGTGACATTTTACATTAAATTTTTTT TACATTTTTTGGGCAGCAATTTAAATGTTATGACTATGTAAACTACTTCTCTTGTTAGGTAATTTTTTTCACCTAGATTTTTTTCCCAAT TGAGAAAAATATATACTAAACAAAATAGCAATAAAACATAATCACTCTATTTGAAGAAAATATCTTGTTTTCTGCCAATAGATTTTTTAA AATGTAGTCAGCAAAATGGGGGTGGGGAAGCAGAGCATGTCCTAGTTCAATGTTGACTTTTTTTTTTTTTAAAGAAAAGCATTAAGACAT >In-frame_ENST00000339591_ENST00000393083_TCGA-85-A50M-01A_ITGB4_chr17_73753898_-_PTN_chr7_136938384_length(amino acids)=1813AA_start in transcript=163_stop in transcript=5604 MAGRGRKRMAGPRPSPWARLLLAALISVSLSGTLANRCKKAPVKSCTECVRVDKDCAYCTDEMFRDRRCNTQAELLAAGCQRESIVVMES SFQITEETQIDTTLRRSQMSPQGLRVRLRPGEERHFELEVFEPLESPVDLYILMDFSNSMSDDLDNLKKMGQNLARVLSQLTSDYTIGFG KFVDKVSVPQTDMRPEKLKEPWPNSDPPFSFKNVISLTEDVDEFRNKLQGERISGNLDAPEGGFDAILQTAVCTRDIGWRPDSTHLLVFS TESAFHYEADGANVLAGIMSRNDERCHLDTTGTYTQYRTQDYPSVPTLVRLLAKHNIIPIFAVTNYSYSYYEKLHTYFPVSSLGVLQEDS SNIVELLEEAFNRIRSNLDIRALDSPRGLRTEVTSKMFQKTRTGSFHIRRGEVGIYQVQLRALEHVDGTHVCQLPEDQKGNIHLKPSFSD GLKMDAGIICDVCTCELQKEVRSARCSFNGDFVCGQCVCSEGWSGQTCNCSTGSLSDIQPCLREGEDKPCSGRGECQCGHCVCYGEGRYE GQFCEYDNFQCPRTSGFLCNDRGRCSMGQCVCEPGWTGPSCDCPLSNATCIDSNGGICNGRGHCECGRCHCHQQSLYTDTICEINYSAIH PGLCEDLRSCVQCQAWGTGEKKGRTCEECNFKVKMVDELKRAEEVVVRCSFRDEDDDCTYSYTMEGDGAPGPNSTVLVHKKKDCPPGSFW WLIPLLLLLLPLLALLLLLCWKYCACCKACLALLPCCNRGHMVGFKEDHYMLRENLMASDHLDTPMLRSGNLKGRDVVRWKVTNNMQRPG FATHAASINPTELVPYGLSLRLARLCTENLLKPDTRECAQLRQEVEENLNEVYRQISGVHKLQQTKFRQQPNAGKKQDHTIVDTVLMAPR SAKPALLKLTEKQVEQRAFHDLKVAPGYYTLTADQDARGMVEFQEGVELVDVRVPLFIRPEDDDEKQLLVEAIDVPAGTATLGRRLVNIT IIKEQARDVVSFEQPEFSVSRGDQVARIPVIRRVLDGGKSQVSYRTQDGTAQGNRDYIPVEGELLFQPGEAWKELQVKLLELQEVDSLLR GRQVRRFHVQLSNPKFGAHLGQPHSTTIIIRDPDELDRSFTSQMLSSQPPPHGDLGAPQNPNAKAAGSRKIHFNWLPPSGKPMGYRVKYW IQGDSESEAHLLDSKVPSVELTNLYPYCDYEMKVCAYGAQGEGPYSSLVSCRTHQEVPSEPGRLAFNVVSSTVTQLSWAEPAETNGEITA YEVCYGLVNDDNRPIGPMKKVLVDNPKNRMLLIENLRESQPYRYTVKARNGAGWGPEREAIINLATQPKRPMSIPIIPDIPIVDAQSGED YDSFLMYSDDVLRSPSGSQRPSVSDDTEHLVNGRMDFAFPGSTNSLHRMTTTSAAAYGTHLSPHVPHRVLSTSSTLTRDYNSLTRSEHSH STTLPRDYSTLTSVSSHGLPPIWEHGRSRLPLSWALGSRSRAQMKGFPPSRGPRDSIILAGRPAAPSWGPDSRLTAGVPDTPTRLVFSAL GPTSLRVSWQEPRCERPLQGYSVEYQLLNGGELHRLNIPNPAQTSVVVEDLLPNHSYVFRVRAQSQEGWGREREGVITIESQVHPQSPLC PLPGSAFTLSTPSAPGPLVFTALSPDSLQLSWERPRRPNGDIVGYLVTCEMAQGGGPATAFRVDGDSPESRLTVPGLSENVPYKFKVQAR TTEGFGPEREGIITIESQDGGPFPQLGSRAGLFQHPLQSEYSSITTTHTSATEPFLVDGLTLGAQHLEAGGSLTRHVTQEFVSRTLTTSG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ITGB4-PTN |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ITGB4-PTN |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ITGB4-PTN |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ITGB4 | C1856934 | Epidermolysis bullosa with pyloric atresia | 11 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | ITGB4 | C0266159 | Pyloric Atresia | 2 | CTD_human |
Hgene | ITGB4 | C0268374 | Adult junctional epidermolysis bullosa (disorder) | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | ITGB4 | C0282160 | Aplasia Cutis Congenita | 2 | CTD_human;ORPHANET |
Hgene | ITGB4 | C0000786 | Spontaneous abortion | 1 | CTD_human |
Hgene | ITGB4 | C0000822 | Abortion, Tubal | 1 | CTD_human |
Hgene | ITGB4 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | ITGB4 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Hgene | ITGB4 | C0013575 | Ectodermal Dysplasia | 1 | CTD_human |
Hgene | ITGB4 | C0014527 | Epidermolysis Bullosa | 1 | CTD_human |
Hgene | ITGB4 | C0017639 | Gliosis | 1 | CTD_human |
Hgene | ITGB4 | C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
Hgene | ITGB4 | C0079297 | Epidermolysis Bullosa Progressiva | 1 | CTD_human |
Hgene | ITGB4 | C0079301 | Junctional Epidermolysis Bullosa | 1 | CTD_human |
Hgene | ITGB4 | C0079683 | Herlitz Disease | 1 | CTD_human |
Hgene | ITGB4 | C0162361 | Hidrotic Ectodermal Dysplasia | 1 | CTD_human |
Hgene | ITGB4 | C0220636 | Malignant neoplasm of salivary gland | 1 | CTD_human |
Hgene | ITGB4 | C1706004 | Anhydrotic Ectodermal Dysplasias | 1 | CTD_human |
Hgene | ITGB4 | C3830362 | Early Pregnancy Loss | 1 | CTD_human |
Hgene | ITGB4 | C3887640 | Astrocytosis | 1 | CTD_human |
Hgene | ITGB4 | C4552766 | Miscarriage | 1 | CTD_human |
Tgene | PTN | C0007097 | Carcinoma | 1 | CTD_human |
Tgene | PTN | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | PTN | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Tgene | PTN | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Tgene | PTN | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
Tgene | PTN | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
Tgene | PTN | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
Tgene | PTN | C0205699 | Carcinomatosis | 1 | CTD_human |
Tgene | PTN | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |